Honorary Fellows’ Directory

Honorary Fellowship is the highest honour that the Society bestows. It is awarded to senior members (or exceptionally to non-members) distinguished by their sustained leadership role in science. This Directory has been created to increase the visibility of our Honorary Fellows and their contributions, and to support networking by providing a useful resource for members to connect with Honorary Fellows with similar areas of interest.

Here you can find profiles of each Honorary Fellow, including information on their institutional affiliation, year elected, primary professional setting, Affinity Group membership, along with a short biography.

Please click the magnifying glass icon to begin any searches.

Filter

Result(s):


Dr Walter Aellig

Swiss Clinical Pharmacologist, now retired.

Professor Tony Avery

Professor Tony Avery, OBE, is a GP, and Professor of Primary Health Care at the University of Nottingham.

Ms Kate Baillie

Kate Baillie was Chief Executive of the Biochemical Society from 2012-2024 and is now retired.

Professor Emma Baker

Professor Emma Baker is Professor of Clinical Pharmacology and honorary consultant at St George’s, University of London.

Dr Y.S. (Mick) Bakhle

I read Chemistry, took Chemical Pharmacology as a Supplementary Subject and went on to a DPhil in the Department of Pharmacology, at Oxford.

Professor Richard Barker

Richard is an internationally respected leader in healthcare and life sciences.

Professor Sir Peter Barnes

Peter Barnes is Margaret Turner-Warwick Professor of Medicine at the National Heart and Lung Institute, was Head of Respiratory Medicine at Imperial College 1987-2017 and Honorary Consultant Physician at Royal Brompton Hospital, London.

Professor David (Nick) Bateman

Nick Bateman trained in clinical pharmacology at the RPMS Hammersmith Hospital.

Professor Maria Belvisi

Professor Maria Belvisi is Senior Vice President and Head of Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D at AstraZeneca and is responsible for the basic science from initiation of projects to Phase 3 clinical trials.